Past investments

• CoStim Pharmaceuticals
• InformedDNA
• Mitobridge
• Verastem Oncology
• CODA Biotherapeutics
• Tetherex Pharmaceuticals
• Motus Therapeutics
• Astute Medical
• Clinical Ink
• iPierian
• Cullinan Oncology
• TriVascular
• Frontier Medicines
• Aktis Oncology
• Entrada Therapeutics
• Atopix Therapeutics
• Trishula Therapeutics
• Aratana Therapeutics
• Harpoon Therapeutics
• Umoja Biopharma
• Radius Health
• Oncorus
• Proteon Therapeutics
• Rhythm Metabolic
• ElevateBio
• Valeritas
• Werewolf Therapeutics
• Repare Therapeutics
• Semma Therapeutics
• Nevro
• Kalidex Pharmaceuticals
• Chiasma
• 23andMe
• Selexys Pharmaceuticals Corporation
• Iconic Therapeutics
• Dyne Therapeutics
• Blade Therapeutics
• Theraclone Sciences
• Vascular Pharmaceuticals
• Celladon
• Raze Therapeutics
• Conatus Pharmaceuticals
• Twentyeight-Seven Therapeutics
• Amphivena Therapeutics
• True North Therapeutics
• SiO2 Medical Products
• Cerecor
• TCR2
• arGEN-X
• Triplet Therapeutics
• NeoVista
• Tizona Therapeutics
• Sideris Pharmaceuticals
• ReCode Therapeutics
• BioIntervene
• Rhythm Pharmaceuticals
• ITeos Therapeutics
• Orna Therapeutics
• IOmx Therapeutics
• Syndax Pharmaceuticals